Dashboard
Manage Tickers

SGMOSANGAMO THERAPEUTICS, INC

Nasdaq sangamo.com


$ 0.88 $ 0.17 (23.61 %)    

Friday, 02-Aug-2024 15:58:33 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 447.95 $ -10.91 (-2.37 %)
DIA $ 397.31 $ -6.10 (-1.51 %)
SPY $ 532.92 $ -10.11 (-1.86 %)
TLT $ 98.17 $ 2.97 (3.12 %)
GLD $ 225.36 $ -0.43 (-0.19 %)
$ 0.8712
$ 0.68
$ 0.86 x 1,200
-- x --
$ 0.65 - $ 0.88
$ 0.29 - $ 1.48
20,016,306
na
157.11M
$ 0.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-13-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-24-2021 12-31-2020 10-K
15 11-04-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 02-28-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-01-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 10-27-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 02-18-2016 12-31-2015 10-K
35 10-30-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 04-28-2015 03-31-2015 10-Q
38 02-25-2015 12-31-2014 10-K
39 10-28-2014 09-30-2014 10-Q
40 07-29-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
07/31/2024 12:20:40

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $5 p...

why-saia-shares-are-trading-lower-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Saia Shares Are Trading Lower? Here Ar...
07/26/2024 17:25:58

peering-into-sangamo-therapeuticss-recent-short-interest
Peering Into Sangamo Therapeutics's Recent...
07/25/2024 20:15:13

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
07/24/2024 19:22:45

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $5 p...

crude-oil-gains-1-att-shares-rise-after-q2-earnings
Crude Oil Gains 1%; AT&T Shares Rise After...
07/24/2024 18:37:16

why-general-dynamics-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why General Dynamics Shares Are Trading Lo...
07/24/2024 17:26:11

dow-tumbles-300-points-tesla-shares-plunge-after-q2-results
Dow Tumbles 300 Points; Tesla Shares Plung...
07/24/2024 16:30:09

sangamo-stock-spikes-as-pfizer-partnership-meets-goal-in-late-stage-study
Sangamo Stock Spikes As Pfizer Partnership...
07/24/2024 16:10:52

Pfizer's Phase 3 AFFINE study of giroctocogene fitelparvovec gene therapy for hemophilia A meets key endpoints, showing a s...

sangamo-therapeutics-shares-resume-trade
Sangamo Therapeutics Shares Resume Trade
07/24/2024 13:43:14

sangamo-therapeutics-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-695
Sangamo Therapeutics Shares Halted On Circ...
07/24/2024 13:37:53

Core News & Articles
Sangamo Therapeutics Announces Pfizer's Ph...
07/24/2024 12:28:17

critical-insights-from-sangamo-therapeutics-analyst-ratings-what-you-need-to-know
Critical Insights From Sangamo Therapeutic...
05/15/2024 15:01:53

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
05/15/2024 14:34:28

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $5 p...

sangamo-therapeutics-q1-2024-gaap-eps-027-misses-022-estimate-sales-481000k-miss-6654m-estimate
Sangamo Therapeutics Q1 2024 GAAP EPS $(0....
05/09/2024 20:30:15

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate o...

sangamo-therapeutics-presents-modular-integrase-technology-engineered-to-enable-large-scale-genome-editing
Sangamo Therapeutics Presents Modular Inte...
05/09/2024 12:45:44

sangamo-therapeutics-to-present-neurology-focused-pre-clinical-data-from-epigenetic-regulation-capsid-delivery-and-genome-engineering-platforms-at-27th-asgct-annual-meeting
Sangamo Therapeutics To Present Neurology-...
04/22/2024 20:36:23

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
03/22/2024 17:31:17

sangamo-therapeutics-announces-pricing-of-24m-registered-direct-offering
Sangamo Therapeutics Announces Pricing Of ...
03/22/2024 12:05:53

Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced that it has entered into a securities pur...

analyst-bullish-on-gene-therapy-focused-voyager-therapeutics-sees-best-in-class-potential-for-its-neurogenetic-medicine-platform
Analyst Bullish On Gene Therapy-Focused Vo...
03/19/2024 18:16:11

Unlock potential with Voyager Therapeutics as HC Wainwright initiates coverage highlights its TRACER capsid platform, promising...

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-raises-price-target-to-5
HC Wainwright & Co. Reiterates Buy on Sang...
03/19/2024 10:25:40

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and raises the pri...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)